A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.

Recruiting now

Conditions studied: Metastatic Colorectal Cancer

In brief

This study aims to comprehensively identify the various treatment patterns of second- or subsequent-line palliative chemotherapy used in patients with metastatic colorectal cancer who have experienced failure of first-line palliative chemotherapy and to evaluate the prognosis of each treatment.

Key facts

Study ID

NCT07263178

Run by

Boryung Pharmaceutical Co., Ltd

People needed

1000

Starts

2025-11-07

Expected to finish

2029-12-01

Last updated by the study team

2025-12-04

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who have signed the informed consent after receiving information about the purpose and method of this study.
• Patients with histologically and radiologically confirmed metastatic colorectal cancer (colorectal cancer) who have evaluable (measurable) lesions.
• Patients scheduled to receive their first second-line palliative chemotherapy following failure of first-line palliative chemotherapy (including those who relapse during or within 6 months after completion of postoperative adjuvant therapy, necessitating palliative chemotherapy).
• Patients who understand the research, are cooperative in the research process, and are deemed capable of participating until the completion date.

You may not qualify if…

• Female patients who are pregnant, have childbearing potential, or are breastfeeding.
• Has received an investigational product within 4 weeks from the study enrollment or has plans to participate in another clinical trial during the participation of this study.
• Other subjects who are considered inappropriate to participate in this study by the judgment of the investigator.

Where it is running

• Samsung Medical Center — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.